DeviceClearance

K974171

Substantially Equivalent

COPAXONE (GLATIRAMER ACETATE FOR INJECTION) EZ-JECT FROM SHARED SOLUTIONS

Applicant
Teva Medical, Ltd.
Product code
KZH
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Kulpsville, PA, US
Download summary PDF View on FDA.gov ↗

Adverse events under product code KZH

product code KZH
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.